
Rapid Diagnostics Market
Description
Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.
Market Dynamics
Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.
For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of β-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).
Key features of the study
Market Dynamics
Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.
For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of β-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).
Key features of the study
- This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.
- Global Rapid Diagnostics Market, By Product
- Consumables
- Instruments/Analysers
- Global Rapid Diagnostics Market, By Prescription
- Professional Diagnostics
- At-Home/OTC-Based Testing
- Global Rapid Diagnostics Market, By Application
- Blood Glucose Testing
- Cardiometabolic Testing
- Infectious Disease Testing
- Blood Coagulation Testing
- Hematology Testing
- Cancer Testing
- Drug of Abuse Testing
- Pregnancy and Fertility/Ovulation Testing
- Global Rapid Diagnostics Market, By End User
- Hospitals and Clinics
- Laboratories
- Individuals/Home Healthcare Settings
- Others
- By Geography
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Companies Insights
- Abbott
- Danaher
- Quidel
- BD
- LifeScan
- Siemens Healthineers
- Hoffmann-La Roche
- Ascensia Diabetes Care Holdings
Table of Contents
168 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Prescription
- Market Snapshot By Application
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in prevalence of chronic/infectious disease
- Stringent regulations and rapid diagnostics challenges
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Rapid Diagnostics Market, By Product, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Instruments/Analysers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 5. Global Rapid Diagnostics Market, By Prescription, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Professional Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- At-Home/OTC-Based Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 6. Global Rapid Diagnostics Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Blood Glucose Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiometabolic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Coagulation Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cancer Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug of Abuse Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pregnancy and Fertility/Ovulation Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 7. Global Rapid Diagnostics Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Individuals/Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 8. Global Rapid Diagnostics Market, By Geography, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- 9. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quidel
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LifeScan
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ascensia Diabetes Care Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
- 10. Section
- Research Methodology
- About us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.